RMO No. 10-2020 removes ATRIG requirements for covered COVID-19 health imports under RA 11469, subject to goods coverage, timing, and reporting rules.
Importers of COVID-19 health equipment, medical supplies, test kits, and qualified materials used to produce emergency health goods may secure release from customs custody without first obtaining an Authority to Release Imported Goods or ATRIG, provided the importation falls within Section 4(o) of Republic Act No. 11469, the Bayanihan to Heal as One Act. For businesses, manufacturers, hospitals, distributors, and logistics teams handling emergency medical imports, RMO No. 10-2020 removes a critical release bottleneck during the public health emergency but also limits the exemption to covered goods, covered importers, and the three-month statutory effectivity period of RA No. 11469 unless extended, withdrawn, or ended by competent authority.
What RMO No. 10-2020 Changed
RMO No. 10-2020 prescribed the policies and guidelines on the exemption from ATRIG requirements for all items imported under Section 4(o) of RA No. 11469. The practical rule is direct and urgent: covered health equipment and supplies declared as critical or needed to address the COVID-19 public health emergency are to be released from customs custody without the need for an ATRIG.
The issuance implements the tax and customs relief recognized under RA No. 11469 and Revenue Regulations No. 6-2020 dated 27 March 2020. Section 4(o) of RA No. 11469 grants exemptions from value-added tax and excise tax on the importation of health equipment and supplies deemed critical or needed to address the public health emergency. RMO No. 10-2020 translates that statutory exemption into an operational customs-release rule by removing the ATRIG requirement for covered importations.
For Philippine tax and customs compliance teams, the most important change is not merely the VAT or excise tax exemption. It is that covered goods may be released without the usual ATRIG process. This matters because ATRIG requirements can delay the movement of imported goods from customs custody, and RA No. 11469 expressly required that distribution of emergency health products should not be unnecessarily delayed.
Who Is Affected
The issuance most directly affects importers, consignees, hospitals, medical suppliers, distributors, manufacturers, logistics providers, and companies bringing into the Philippines COVID-19-related health equipment and supplies. It is also important for customs brokers, tax managers, CFOs, and corporate accountants who need to determine whether an importation may be released without an ATRIG.
Manufacturers are also specifically affected. RMO No. 10-2020 provides that materials needed to produce covered health equipment and supplies shall likewise be released from customs custody without need of an ATRIG, provided that the importing manufacturer is included in the Master List of the Department of Trade and Industry and other incentive-granting bodies. This is a significant condition. A manufacturer importing raw materials or components cannot rely only on the intended use of the goods; it must also consider whether it is included in the relevant Master List.
Covered Health Equipment and Supplies
RMO No. 10-2020 states that all importations of health equipment and supplies deemed critical or needed to address the current public health emergency, and declared as exempt from VAT and excise taxes under Section 4(o) of RA No. 11469, shall be released from customs custody without need of an ATRIG.
The covered items include personal protective equipment such as gloves, gowns, masks, goggles, face shields, surgical equipment, and supplies. They also include laboratory equipment and reagents, medical equipment and devices, support and maintenance items for laboratory and medical equipment, and surgical equipment and supplies.
The issuance also covers medical supplies, tools, and consumables, including alcohol, sanitizers, tissue, thermometers, hand soap, detergent, sodium hypochlorite, cleaning materials, povidone iodine, and common medicines. The listed examples of common medicines include paracetamol tablets and suspension, mefenamic acid, vitamins tablets and suspension, hyoscine tablets and suspension, oral rehydration solution, and cetirizine tablets and suspension.
COVID-19 testing kits are expressly covered. The coverage may also extend to other goods identified by the Department of Health and other relevant government agencies. For businesses searching for ATRIG exemption COVID test kits, Bayanihan Act VAT exemption importation, or BIR ATRIG health supplies, this is the key rule: the exemption depends on whether the goods are within the emergency health equipment and supplies contemplated by Section 4(o) and the implementing BIR guidelines.
Covered Production Materials for Manufacturers
RMO No. 10-2020 separately addresses importation of materials needed to produce the health equipment and supplies deemed critical or needed for the public health emergency. These materials may also be released from customs custody without an ATRIG.
However, the rule is subject to an important qualification: the importing manufacturer must be included in the Master List of the Department of Trade and Industry and other incentive-granting bodies. This means manufacturers should retain proof of their inclusion in the relevant Master List and coordinate with customs brokers before shipment arrival or declaration, especially where the goods are production inputs rather than finished medical supplies.
Key Compliance Requirements and Reporting
Although the ATRIG requirement is removed for covered importations, RMO No. 10-2020 does not mean that importers may disregard documentation. The Bureau of Customs is directed to furnish the Commissioner of Internal Revenue with a summary report of all importations availing of the privilege under Section 4(o) of RA No. 11469.
The summary report must include the name of the consignee or importer, the tax identification number if available, the description of goods, the invoice value of the goods, and the date of arrival of the goods. These details matter because they create a traceable compliance record for the VAT and excise tax exemption and the ATRIG release privilege.
For corporate accountants and customs brokers, the practical implication is that import entries, invoices, goods descriptions, and consignee or importer information must be consistent. If a company claims that the goods are exempt emergency health equipment or supplies, its customs documents should clearly support that classification. Loose or generic descriptions may create audit risk later, especially where the goods are high-value medical devices, test kits, or production inputs.
Validity Period and Effective Date
RMO No. 10-2020 is dated 30 March 2020 and takes effect immediately. The exemption from the ATRIG requirement covers importations of health equipment and supplies under Section 4(o) of RA No. 11469 that arrived and were declared by the Bureau of Customs during the three-month effectivity of RA No. 11469, unless extended or withdrawn by Congress or ended by Presidential Proclamation.
The issuance also notes that RA No. 11469 was published and deemed effective on 26 March 2020. Businesses reviewing past importations should therefore pay close attention to the arrival date and customs declaration date. The release privilege is not written as a permanent ATRIG exemption; it is tied to the emergency framework of RA No. 11469.
All revenue issuances inconsistent with RMO No. 10-2020 are deemed amended during the effectivity period of RA No. 11469. The order is automatically repealed upon the lifting of the emergency powers through the expiration of the three-month period, unless extended or withdrawn by Congress or ended by Presidential Proclamation.
Penalties and Consequences for Non-Compliance
RMO No. 10-2020 contains a specific penalty clause directed at strict compliance. Any violation of the provisions of the order and RA No. 11469 shall be subject to disciplinary action and shall be dealt with accordingly.
While the issuance does not state a separate tax surcharge, interest rate, or monetary fine, taxpayers and importers should not treat the absence of a stated peso penalty as low risk. A wrongful claim of exemption may expose the parties to assessment, customs consequences, loss of release privileges, administrative action, and questions during later BIR or customs review. The safer approach is to document the legal basis for exemption before release and to keep the import records ready for audit.
Practical Steps for Importers, CFOs, and Tax Teams
First, classify the imported goods carefully. Confirm whether they are health equipment, medical supplies, COVID-19 testing kits, covered medicines, laboratory equipment, PPE, or other goods identified by the Department of Health or relevant agencies. The goods description should be specific enough to match the covered category.
Second, confirm whether VAT and excise tax exemption under Section 4(o) of RA No. 11469 is being claimed. The ATRIG exemption in RMO No. 10-2020 is tied to goods declared exempt under that provision. If the importation does not fall within the statutory emergency exemption, the ordinary ATRIG rules may still be relevant.
Third, for production materials, verify whether the importing manufacturer is included in the Master List of the Department of Trade and Industry and other incentive-granting bodies. This is especially important for companies importing inputs, components, or raw materials used to manufacture health equipment and supplies.
Fourth, prepare complete customs and tax documentation. The Bureau of Customs reporting to the BIR includes the consignee or importer name, TIN if available, goods description, invoice value, and date of arrival. Companies should ensure these details match their internal accounting records and import files.
Fifth, check the timing. RMO No. 10-2020 applies to importations that arrived and were declared by the Bureau of Customs during the three-month effectivity of RA No. 11469, unless the legal period was extended, withdrawn, or ended by Presidential Proclamation. Timing can determine whether the ATRIG exemption applies.
Why This Matters for BIR and Customs Compliance
RMO No. 10-2020 is a good example of a tax rule that has both immediate operational value and later audit implications. It allowed covered emergency health goods to move faster by removing the ATRIG requirement, but it did not eliminate the need for accurate classification, documentary support, and compliance discipline.
Common search terms for this issuance include RMO No. 10-2020 ATRIG exemption, Bayanihan Act VAT exemption imports, COVID-19 medical supplies ATRIG, BIR ATRIG requirements health equipment, and Section 4(o) RA 11469 importation. For businesses, the real issue behind those searches is whether goods can be released without ATRIG and how to defend that treatment if questioned later.
How Ablola, Saribong & Gueco Can Help
Ablola, Saribong & Gueco advises businesses, importers, manufacturers, distributors, and regulated companies on Philippine tax compliance, BIR issuances, customs documentation, VAT and excise tax issues, and audit-risk management. For companies that imported emergency health goods, medical supplies, COVID-19 test kits, or production materials under RA No. 11469, legal review is useful to confirm whether the ATRIG exemption was properly claimed and documented.
Our Makati-based tax and business law team can assist in reviewing import documents, preparing compliance positions, assessing exposure from disputed exemptions, and coordinating tax-sensitive documentation for future BIR or customs inquiries. For assistance with BIR compliance, ATRIG issues, VAT and excise tax exemptions, or import-related tax risk, contact Ablola, Saribong & Gueco through MakatiLawFirm.com.